ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Verastem
Verastem Oncology is seeking a Vice President, Commercial Strategy and New Product Planning to define commercial strategies and new product plans for its pipeline, including the KRAS G12D inhibitor VS-7375. This role involves leading cross-functional teams to drive product strategy through market insights, competitive analysis, and strategic marketing activities. The position requires a leader with extensive experience in pharmaceutical product development and oncology to shape the future of cancer care.
Headquarters
Needham Heights, Massachusetts, United States
Company Size
51-200 employees
Founded
2010
Verastem Oncology is a biopharmaceutical company focused on developing and delivering novel therapies for RAS/MAPK pathway-driven cancers. The company has advanced the first FDA-approved treatment for KRAS-mutant recurrent low-grade serous ovarian cancer and maintains a pipeline of small molecule inhibitors targeting KRAS G12D, RAF/MEK, and FAK pathways. Verastem leverages strategic collaborations and ongoing clinical trials to address significant unmet needs across multiple solid tumor types.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Verastem.
Director, Global Marketing GI Oncology (New Product Planning)
BioLife Plasma Services
Sr. Manager, Business Development
MacroGenics
Director, Global Commercial Strategy, Iza-bren
Bristol Myers Squibb
Vice President
Revolution Medicines
Senior Manager, New Product Planning
Avalyn Pharma
Vice President, Radioconjugate Development
AstraZeneca